Belgium – Immunoglobulins – Immunoglobulinen
Opportunity Score
Confidence: 50%
Complexity: medium
0 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender is a framework agreement for the supply of immunoglobulins to a Belgian healthcare buyer (Onze Lieve Vrouw Van Troost v.z.w., Dendermonde) for 48 months. The procedure is open with one contractor selected based on cost (60%) and quality (40%) criteria. Submission is electronic via the Belgian e-procurement platform, with documents and submissions required in Dutch. The estimated framework maximum value is EUR 4,242,186. There are data inconsistencies regarding multiple lots, and procurement documents were not analyzed.
Strengths
Documents available
Open procedure
Medium complexity
Risks
Submission deadline in 0 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Open procedure with electronic submission required.
- Submitted in Dutch language.
- No variants allowed.
Buyer
Name
Onze Lieve Vrouw Van Troost v.z.w.
Location
Dendermonde, BEL
Website
Identifier
OLV Van Troost
Lots (3)
Framework agreement for on-call supply of immunoglobulins (CPV 33651520) for 48 months. Single contractor. Place of performance: Dendermonde, Belgium.
Incomplete lot data in structured data; no additional details provided.
Incomplete lot data in structured data; no additional details provided.
Procurement Details
Publication
14 May 2026
Deadline
15 Jun 2026, 08:00
Procedure
open
Contract
supplies
Duration
48 MONTH
Language
NLD
Publication #
331121-2026
Classification
Performance: Belgium
Documents (2)
Opportunity Score
Confidence: 50%
Complexity: medium
0 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation